Indo Us Bio-Tech (INDOUS.NS) Stock Price
Indo Us Bio-Tech Price
Over the last 12 years Indo Us Bio-Tech grew revenue by 18.2% annually, reaching 1.10 B INR. Earnings per share have grown at 23.3% per year over the last 12 years. For Indo Us Bio-Tech, the net margin of 11.9% is up versus 10.1% a few years ago. At today's price the dividend yield works out to roughly 0.34%. The payout ratio is around 6% of earnings. The dividend has grown at 4.7% per year over the past 4 years.
Indo Us Bio-Tech stock price
Indo Us Bio-Tech business model & stock analysis
Frequently asked questions about Indo Us Bio-Tech
Converted at the current exchange rate, the Indo Us Bio-Tech share trades at 0.67 EUR (72.50 INR).
The revenue of Indo Us Bio-Tech is 1.10 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Indo Us Bio-Tech is 131.23 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Indo Us Bio-Tech is currently 11.08. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Indo Us Bio-Tech stock.
The price-to-sales ratio (P/S) of Indo Us Bio-Tech is currently 1.32. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Indo Us Bio-Tech stock.
The Eulerpool Quality Score for Indo Us Bio-Tech is 6/10.
The ISIN of Indo Us Bio-Tech is INE250Z01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Indo Us Bio-Tech is INDOUS.NS. The ticker symbol is used to trade Indo Us Bio-Tech shares on the stock exchange.
Indo Us Bio-Tech stock
Indo Us Bio-Tech Peer Group
Indo Us Bio-Tech FIGI
All fundamentals and in-depth analysis of Indo Us Bio-Tech
Our stock analysis for Indo Us Bio-Tech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indo Us Bio-Tech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.